Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Resverlogix Corp T.RVX

Alternate Symbol(s):  RVXCF

Resverlogix Corp. is a Canada-based late-stage biotechnology company. The Company is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The Company's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the treatment of cardiovascular disease and associated comorbidities, and post-COVID-19 conditions. RVX-208 is a small molecule that is a selective bromodomain and extra-terminal (BET) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. RVX-208 is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. It partners with EVERSANA, to support the commercialization of RVX-208 for cardiovascular disease, post-COVID-19 conditions, and pulmonary arterial hypertension in Canada and the United States.


TSX:RVX - Post by User

Bullboard Posts
Post by ronrydellon Apr 16, 2015 4:27pm
289 Views
Post# 23638009

My guess on today...

My guess on today........is that we drank the kool aid that there might be some licensing opportunities win the Chinese, many posts describing the diabetics of China, coupled with the perception that a Chinese patent has the same credibility of an Iranian nucluler agreement made this a big drop today.

For many people with a very low current basis after a Dec sale and a January buyback...our biggest problem is/when knowing when to sell on a run up and not trying to get every last dollar. This runup will happen again if/when Phase III annoucements are made. Again the big decision "to sell or not to sell" how much to sell, how much to hold". Will this become a home run? I do think a Phase III trial annoucement should give us a small bump. In the meantime....this is the worst stock I've ever seen for the ups and downs, the pump and dump, the munipulation, etc. Buy the rumor/speculation and sell the event.....a very familiar history. :(
Bullboard Posts